Qinhua Ru, PhD

Managing Director, CRC Oncology

Professional Overview
Qinhua Ru, PhD, is an accomplished scientific and business leader with over 15 years of experience in the pharmaceutical and biotechnology industries. As the Managing Director of CRC Oncology, he is responsible for driving the strategic direction and operational excellence of the company's oncology portfolio, with a focus on developing innovative therapies to address unmet medical needs.

Experience Summary

Current Role
As the Managing Director of CRC Oncology, Dr. Ru oversees all aspects of the company's oncology business, including research and development, clinical trial management, regulatory affairs, and commercial strategy. Under his leadership, CRC Oncology has expanded its pipeline of promising cancer treatments and secured several strategic partnerships with leading industry players. Dr. Ru's deep scientific expertise and strong business acumen have been instrumental in positioning CRC Oncology as a key player in the competitive oncology landscape.

Career Progression
Prior to joining CRC Oncology, Dr. Ru held several senior-level positions in the pharmaceutical and biotechnology sectors. He served as the Executive Vice President and Chief Scientific Officer at CARsgen Therapeutics, where he led the development of their innovative cell therapy platform. He also held the role of Chief Scientific Officer at Sihuan Pharmaceutical Co., Ltd., where he was responsible for overseeing the company's R&D efforts and driving the growth of its drug portfolio. Earlier in his career, Dr. Ru held leadership positions at Pfizer and Exelixis, where he made significant contributions to the development and commercialization of several groundbreaking oncology therapies.

Academic Background
Dr. Ru holds a PhD in Pharmaceutical Sciences from the University of California, San Francisco, where he specialized in the development of novel cancer treatments. He has authored numerous peer-reviewed publications and is a recognized expert in the field of oncology drug development.

Areas of Expertise

• Oncology drug development and clinical trial management

• Regulatory affairs and market access strategy

• Translational research and biomarker identification

• Strategic partnership and alliance management

• Team building and leadership in a fast-paced, dynamic environment

Professional Impact
During his career, Dr. Ru has played a pivotal role in the successful development and approval of several innovative oncology therapies. His contributions have led to the improvement of patient outcomes and the advancement of the field of oncology. Dr. Ru is a respected thought leader in the industry and is frequently invited to speak at major conferences and events.

Conclusion
With his extensive expertise, track record of success, and visionary leadership, Qinhua Ru is poised to drive CRC Oncology's continued growth and impact in the field of oncology. As the Managing Director, he is committed to leveraging the company's scientific and commercial capabilities to develop transformative cancer treatments that improve the lives of patients worldwide.